ELVIRA FAW: Open Payments
NPI 1417422056 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,146 in 164 payments from 18 companies in 2025. Trend: 2023 $4,773 · 2024 $3,431 · 2025 $3,146
Food & beverage: $2,992Education: $154
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 58 | $885 |
| ABBVIE INC. | 35 | $672 |
| UCB, Inc. | 16 | $365 |
| Lilly USA, LLC | 8 | $242 |
| Amgen Inc. | 12 | $201 |
| E.R. Squibb & Sons, L.L.C. | 5 | $127 |
| PFIZER INC. | 6 | $124 |
| GlaxoSmithKline, LLC. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Sandoz Inc. | 3 | $64 |
Products named: TREMFYA, RINVOQ, Bimzelx, SKYRIZI, XELJANZ, BENLYSTA, TALTZ, ORENCIA.
Industry payments across NY — which companies pay providers there.
